Does mass spectrometric breath analysis detect Pseudomonas aeruginosa in cystic fibrosis?

Eur Respir J. 2016 Mar;47(3):994-7. doi: 10.1183/13993003.00944-2015. Epub 2016 Feb 4.

Authors

Rishi Pabary¹, Juzheng Huang², Sacheen Kumar², Eric W F W Alton³, Andrew Bush⁴, George B Hanna², Jane C Davies⁴

Affiliations

¹ National Heart and Lung Institute, Imperial College, London, UK Dept of Paediatric Respiratory Medicine, Royal Brompton Hospital, London, UK [email protected].
² Dept of Surgery and Cancer, St Mary's Hospital, London, UK.
³ National Heart and Lung Institute, Imperial College, London, UK.
⁴ National Heart and Lung Institute, Imperial College, London, UK Dept of Paediatric Respiratory Medicine, Royal Brompton Hospital, London, UK.

PMID: 26846826
DOI: 10.1183/13993003.00944-2015

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Biomarkers / analysis
Breath Tests / methods*
Cystic Fibrosis / complications*
Cystic Fibrosis / microbiology
Humans
Logistic Models
Mass Spectrometry*
Pseudomonas Infections / diagnosis*
Pseudomonas aeruginosa / isolation & purification*
Volatile Organic Compounds / analysis*

Substances

Biomarkers
Volatile Organic Compounds